Invasive candidiasis remains a leading cause of morbidity and mortality in various categories of patients at risk.
An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old / Bassetti, M., Giacobbe, D.R., Vena, A., Esposito, S.. - In: EXPERT OPINION ON PHARMACOTHERAPY. - ISSN 1465-6566. - (2022). [10.1080/14656566.2022.2147824]
An overview of micafungin as a treatment option for invasive candidiasis in pediatric patients younger than 4 months old
Esposito, Susanna
2022-01-01
Abstract
Invasive candidiasis remains a leading cause of morbidity and mortality in various categories of patients at risk.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
